PLLW.F logo

Polarean Imaging OTCPK:PLLW.F Stock Report

Last Price

US$0.021

Market Cap

US$18.7m

7D

5.0%

1Y

n/a

Updated

02 Feb, 2025

Data

Company Financials +

Polarean Imaging plc

OTCPK:PLLW.F Stock Report

Market Cap: US$18.7m

PLLW.F Stock Overview

Operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. More details

PLLW.F fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Polarean Imaging plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Polarean Imaging
Historical stock prices
Current Share PriceUK£0.021
52 Week HighUK£0.052
52 Week LowUK£0.01
Beta0.29
1 Month Change40.00%
3 Month Change5.00%
1 Year Changen/a
3 Year Change-97.38%
5 Year Changen/a
Change since IPO-91.15%

Recent News & Updates

Recent updates

Shareholder Returns

PLLW.FUS Medical EquipmentUS Market
7D5.0%-0.08%-0.8%
1Yn/a13.6%22.7%

Return vs Industry: Insufficient data to determine how PLLW.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how PLLW.F performed against the US Market.

Price Volatility

Is PLLW.F's price volatile compared to industry and market?
PLLW.F volatility
PLLW.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.8%
Market Average Movement6.4%
10% most volatile stocks in US Market18.7%
10% least volatile stocks in US Market3.2%

Stable Share Price: PLLW.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PLLW.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201629Chris Von Jakopolarean.com

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags.

Polarean Imaging plc Fundamentals Summary

How do Polarean Imaging's earnings and revenue compare to its market cap?
PLLW.F fundamental statistics
Market capUS$18.71m
Earnings (TTM)-US$8.55m
Revenue (TTM)US$1.87m

10.0x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PLLW.F income statement (TTM)
RevenueUS$1.87m
Cost of RevenueUS$1.03m
Gross ProfitUS$836.63k
Other ExpensesUS$9.38m
Earnings-US$8.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0071
Gross Margin44.78%
Net Profit Margin-457.39%
Debt/Equity Ratio0%

How did PLLW.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 08:17
End of Day Share Price 2025/01/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Polarean Imaging plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colin SmithCapital Access Group
Christian GlennieStifel, Equities Research
null nullStifel, Equities Research